middle.news
How Resonance Health’s $13.8M Pharma Contract Fuels Its Clinical Trials Expansion
4:11am on Saturday 30th of August, 2025 AEST
•
Healthcare
Read Story
How Resonance Health’s $13.8M Pharma Contract Fuels Its Clinical Trials Expansion
4:11am on Saturday 30th of August, 2025 AEST
Key Points
29% revenue growth to $11.07 million in FY25
Net loss of $1.73 million after prior year profit
Acquisition and expansion of TrialsWest clinical trial sites
Secured $13.8 million CRO contract with global pharma
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Resonance Health (ASX:RHT)
OPEN ARTICLE